Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Apr 2026 and Sep 2026.
- Largest single sale: $1.4M (37,255 shares) of Kiniksa Pharmaceuticals International, plc on Oct 20, 2025. Filing
- Last sale before this period: Sep 3, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | Chief Accounting Officer | Feb 13, 2020 | Sep 3, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 3, 2026, Kiniksa Pharmaceuticals International, plc: sold 4,600 shares for $369K, under a disclosed plan. 1 filing: 1
- Sep 1, 2026, Kiniksa Pharmaceuticals International, plc: 11,496 shares vested; 5,531 shares withheld by the company for taxes. 1 filing: 1
- Jul 15, 2026, Kiniksa Pharmaceuticals International, plc: 279 shares awarded. 1 filing: 1
- Apr 9, 2026, Kiniksa Pharmaceuticals International, plc: sold 6,625 shares for $309K, under a disclosed plan. 1 filing: 1
- Apr 7, 2026, Kiniksa Pharmaceuticals International, plc: 3,932 shares vested; 1,666 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.